# 68Ga-FAPI PET/CT to Detect Ongoing Fibroblast Activity in Post-acute COVID-19

> **NCT05981885** · — · COMPLETED · sponsor: **University Medical Center Groningen** · enrollment: 18 (actual)

## Conditions studied

- Post-Acute COVID-19
- Post-Acute COVID-19 Infection
- Post-Acute COVID-19 Syndrome
- Pulmonary Fibrosis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05981885
- **Lead sponsor:** University Medical Center Groningen
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-06-09
- **Primary completion:** 2023-11-21
- **Final completion:** 2024-05-17
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2024-05-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05981885

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05981885, "68Ga-FAPI PET/CT to Detect Ongoing Fibroblast Activity in Post-acute COVID-19". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT05981885. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*